These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 29500859)

  • 1. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
    Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C
    IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.
    Shi C; Huang D; Lu N; Chen D; Zhang M; Yan Y; Deng L; Lu Q; Lu H; Luo S
    Oncotarget; 2016 May; 7(18):26206-19. PubMed ID: 27036048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
    Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
    Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.
    Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J
    Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
    Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
    Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction.
    Wang Z; Teng D; Li Y; Hu Z; Liu L; Zheng H
    Life Sci; 2018 Jun; 203():83-91. PubMed ID: 29678742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
    Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
    PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
    Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L
    PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
    Wang Y; Huang Q; Deng T; Li BH; Ren XQ
    Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
    Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
    Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
    Li B; Shao Q; Ji D; Li F; Guo X; Chen G
    Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
    Jiang W; Wu T; Shi X; Xu J
    Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear‑cell carcinoma cells.
    Kawai Y; Shibata K; Sakata J; Suzuki S; Utsumi F; Niimi K; Sekiya R; Senga T; Kikkawa F; Kajiyama H
    Oncol Rep; 2018 Jul; 40(1):195-205. PubMed ID: 29749467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma.
    Wang W; Wang L; Xie X; Yan Y; Li Y; Lu Q
    BMC Cancer; 2021 Jan; 21(1):6. PubMed ID: 33402113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DHX33 expression is increased in hepatocellular carcinoma and indicates poor prognosis.
    Tian QH; Zhang MF; Luo RG; Fu J; He C; Hu G; Zeng JS
    Biochem Biophys Res Commun; 2016 May; 473(4):1163-1169. PubMed ID: 27073163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis.
    Tian M; Liu W; Jin L; Jiang X; Yang L; Ding Z; Shen Y; Peng Y; Gao D; Li L; Zhou J; Qiu S; Dai Z; Fan J; Shi Y
    Int J Clin Exp Pathol; 2015; 8(4):3892-900. PubMed ID: 26097573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.